AIM ImmunoTech Inc. Up to $8,500,000 Shares of Common Stock Equity Distribution AgreementEquity Distribution Agreement • April 19th, 2023 • AIM ImmunoTech Inc. • Biological products, (no disgnostic substances) • New York
AIM ImmunoTech Inc., a Delaware corporation (the “Company”), proposes to issue and sell through Maxim Group LLC (the “Agent”), as sales agent, shares of common stock, par value $0.001 per share (“Common Stock”), of the Company (the “Shares”) having an aggregate offering price of up to $8,500,000 on terms set forth herein. The Shares consist entirely of authorized but unissued shares of Common Stock to be issued and sold by the Company.
